New study shows antibodies need a strong core — not just grip — to fight SARS-CoV-2
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Jun-2026 20:16 ET (4-Jun-2026 00:16 GMT/UTC)
An international team led by Dr. Adolfo Poma (IPPT PAN, Poland) shows that antibody effectiveness depends not only on binding strength but also on their stability under mechanical forces. The findings provide a new framework for designing more robust antiviral therapeutics.
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help determine vaccine effectiveness. The study, published in the April 29, 2026 online issue of Nature Biotechnology https://doi.org/10.1038/s41587-026-03099-z], also introduces a powerful and versatile technology to control the expression of mRNA drugs, which the researchers demonstrate can enhance the effectiveness of mRNA cancer vaccines in preclinical studies of lymphoma. The findings provide a new framework for designing mRNA vaccines and mRNA therapeutics, with immediate implications for cancer immunotherapy, infectious disease vaccines, and gene-editing treatments.
The platform integrates multi-omic data to drive both biomedical research and clinical practice.
Its technology, based on Graph Foundation Models, extracts robust conclusions even from the limited and heterogeneous samples typical of the biomedical field.
A study led by Professor Bing Liu and Researcher Ang Li reveals that neuroticism contains two distinct dimensions with opposing health effects. While general neuroticism is linked to mental disorders, a newly identified dimension called ERIS shows that individuals prone to worry actually live longer—suggesting different dimensions of neuroticism serve distinct evolutionary missions: “ensuring survival” versus “pursuing happiness.”
An IR Sant Pau study analyzes for the first time the medium-term impact of angiogenic status during pregnancy on memory function in a period less influenced by postpartum-related factors.
The results, published in the American Journal of Obstetrics and Gynecology, provide new evidence on the role of the vascular system in women’s cognitive health in the medium and long term.
The study suggests that this imbalance could act as a risk marker beyond preeclampsia, as it reflects a vascular process with potentially persistent implications.